Our data demonstrate that CsA‐mediated modulation of CypA significantly increases NSCLC sensitivity to chemotherapy, thereby expanding our understanding of how CsA reverses drug resistance. This evidence concerns the gene PPIA and non-small cell lung carcinoma.